Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities
2021-001696-16Phase 2Active
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sotorasib in non-small cell lung cancer (NSCLC), sponsored by Vestre Viken Hospital Trust. Primary endpoint: Objective Response Rate. Started Aug 2021; status: active.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2021-001696-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001696-16.